Skip to Main Content

Author Details

Jasmin Bartl
German Cancer Research Center (DKFZ)
2007
33
15
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36639156Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.J Immunother Cancer2023
37656187Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.Acta Neuropathol2023
35307743Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis.Neuro Oncol2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
36524111Three-dimensional analyses of vascular network morphology in a murine lymph node by X-ray phase-contrast tomography with a 2D Talbot array.Front Immunol2022
36127323Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors.Cell Death Dis2022
34584066The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.Cell Death Dis2021
33866410Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.Acta Neuropathol2021
29230040Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations.Eur J Hum Genet2018
30205043Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.Cancer Cell2018
29491375Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways.Transl Psychiatry2018
28690202The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.Prog Neuropsychopharmacol Biol Psychiatry2017
26110057Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.J Mol Psychiatry2015
24269370Enhancement of cell viability after treatment with polyunsaturated fatty acids.Neurosci Lett2014
24581833Further evidence for plasma progranulin as a biomarker in bipolar disorder.J Affect Disord2014
24334724Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.J Alzheimers Dis2014
24272680Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.J Neural Transm (Vienna)2014
22332892Alzheimer's disease and type 2 diabetes: two diseases, one common link?World J Biol Psychiatry2013
25408903Correction: Methylphenidate enhances neural stem cell differentiation.J Mol Psychiatry2013
25408898Methylphenidate enhances neural stem cell differentiation.J Mol Psychiatry2013
24156256Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.Curr Alzheimer Res2013
22782687Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.J Neural Transm (Vienna)2013
22833045In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.J Neural Transm (Vienna)2013
22562805Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood.Atten Defic Hyperact Disord2012
20652834Methyl- and acetyltransferases are stable epigenetic markers postmortem.Cell Tissue Bank2011
22107728Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.BMC Med Genet2011
20552313Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?Neurotox Res2011
20556444The link between iron, metabolic syndrome, and Alzheimer's disease.J Neural Transm (Vienna)2011
21432609Effects of methylphenidate: the cellular point of view.Atten Defic Hyperact Disord2010
18603262Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.J Psychiatr Res2009
19276557Gene expression as peripheral biomarkers for sporadic Alzheimer's disease.J Alzheimers Dis2009
17361039Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.J Alzheimers Dis2007
18198416Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.J Alzheimers Dis2007
  • 1 - 33 of 33

Recommended Authors

China Tobacco Jiangsu Industrial Co. Ltd.
Career Start Year 2007
Number of shared co-authors 0
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 2006
Number of shared co-authors 0
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 0
Center for Neurodegenerative Science, Van Andel Research Institute
Career Start Year 2005
Number of shared co-authors 0
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 2004
Number of shared co-authors 0
Sean M. Healey & AMG Center for ALS at Mass General
Career Start Year 2003
Number of shared co-authors 0
Department of Pharmacy, Fuzhou Second Hospital
Career Start Year 2003
Number of shared co-authors 0
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 2001
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1999
Number of shared co-authors 0
Karolinska Institute
Career Start Year 1999
Number of shared co-authors 0
The Translational Genomics Research Institute (TGen)
Career Start Year 1998
Number of shared co-authors 1
Texas Tech University Health Sciences Center
Career Start Year 1997
Number of shared co-authors 0
Center for Bionano Intelligence Education and Research, Hanyang University
Career Start Year 1995
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1994
Number of shared co-authors 4
The Picower Institute for Learning and Memory, Massachusetts Institute of Technology
Career Start Year 1991
Number of shared co-authors 0
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 0
Institute for Biomedicine, Affiliated institute of the University of Lubeck
Career Start Year 1990
Number of shared co-authors 0
Istituto Italiano di Tecnologia
Career Start Year 1989
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 1988
Number of shared co-authors 2
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Career Start Year 1988
Number of shared co-authors 2
University of Brescia
Career Start Year 1985
Number of shared co-authors 0
University of Oslo, Oslo University Hospital
Career Start Year 1984
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 1983
Number of shared co-authors 2
Karolinska Institutet.
Career Start Year 1982
Number of shared co-authors 4
Georgetown University
Career Start Year 1981
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1980
Number of shared co-authors 0
George Mason University
Career Start Year 1980
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 0
Abigail Wexner Research Institute, Nationwide Children's Hospital
Career Start Year 1976
Number of shared co-authors 0
University of California San Diego
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Co-authored papers 22
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 9
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 8
Heinrich Heine University
Co-authored papers 8
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers 8
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 8
German Cancer Research Center (DKFZ)
Co-authored papers 8
Co-authored papers 7
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 6
Universitatsklinikum
Co-authored papers 6
Universitatsklinikum
Co-authored papers 5
German Cancer Research Center (DKFZ)
Co-authored papers 5
German Cancer Research Center (DKFZ)
Co-authored papers 4
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Co-authored papers 4
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 4
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 3
Necker Hospital, Assistance Publique-Hopitaux de Paris
Co-authored papers 3
German Cancer Research Center (DKFZ)
Co-authored papers 3
Heinrich-Heine University Dusseldorf
Co-authored papers 3
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 3
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 3
Guangzhou University
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 2
Co-authored papers 2
Hospital for Sick Children
Co-authored papers 2
Co-authored papers 2
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 2